COMBINED THERAPY CANCER THERAPY

• 收藏
• 分享

专利权人:

ЯНССЕН ФАРМАЦЕВТИКА НВ

发明人:

Ю, Маргарет К.,Снайдер, Линда Энн,Маргарет К.,Линда Энн

申请号：

EA201992430

公开号：

EA201992430A1

申请日:

2018.04.09

申请国别(地区):

EA

年份:

2020

代理人:

摘要：

Provided are methods and compositions, for treating prostate cancer by administering to a patient in need thereof a therapeutically effective amount of a PARP inhibitor, e.g., niraparib； a therapeutically effective amount of a CYP17 inhibitor, e.g., abiraterone acetate, and a therapeutically effective amount of a glucocorticoid, e.g., prednisone.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/